Tue, Sep 23, 2014, 10:38 AM EDT - U.S. Markets close in 5 hrs 22 mins


% | $
Quotes you view appear here for quick access.

Insmed Incorporated Message Board

  • bohemianclubman bohemianclubman Mar 22, 2013 6:37 AM Flag


    Someone is always saying that Insmed doesn't have enough analyst coverage to own the shares.

    It's better to own the shares and then get the coverage. cannacord - 12 dollar target

    Others are always saying that getting a drug to market is and always will be a long, arduous, painstakng process. They are correct of course. However, the 2012 FDASIA, complete with QUIP and Breakthrough Designation is changing that:

    The best description of the pathway may have been delivered by Center for Drug Evaluation & Research Director Janet Woodcock during hearings on FDASIA: she said that the “breakthrough” designation would encourage the sponsor and the agency to call “all hands on deck” to rethink the development plan rather than plow through a traditional Phase 1-2-3 process.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
12.69-0.15(-1.17%)10:37 AMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.